XM does not provide services to residents of the United States of America.
P
P

Pfizer

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

US CDC alerts healthcare providers of increase in meningococcal disease

UPDATE 2-US CDC alerts healthcare providers of increase in meningococcal disease Adds details in paragraphs 4-7, background throughout March 28 (Reuters) - The U.S. Centers for Disease Control and Prevention issued an advisory on Thursday alerting healthcare providers about an increase in invasive meningococcal disease and urging them to ensure necessary vaccinations against the deadly disease.
P

J&J can contest evidence linking its talc to cancer, US judge rules

UPDATE 3-J&J can contest evidence linking its talc to cancer, US judge rules Adds details from the ruling and background about the litigation from paragraph 13 By Dietrich Knauth NEW YORK, March 27 (Reuters) - Johnson & Johnson JNJ.N will get a new chance to contest the scientific evidence linking talc to ovarian cancer, a federal judge ruled on Wednesday, potentially disrupting more than 53,000 lawsuits the company is now facing over its talc products.
P
S

China to speed up 'new productive forces', vice president says

UPDATE 1-China to speed up 'new productive forces', vice president says Adds comments from Pfizer, AstraZeneca, details on summit throughout By Joe Cash and Sarah Wu BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng t old an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.
A
P

German industry sceptical of China's vow to treat foreign firms equally

German industry sceptical of China's vow to treat foreign firms equally China pledges equal treatment for foreign firms German VDMA: announcement part of 'friendly signs' offensive Move aimed at keeping foreign firms engaged in China By Christoph Steitz and Rene Wagner FRANKFURT/BERLIN, March 25 (Reuters) - A fresh pledge by Beijing to treat foreign companies like domestic rivals drew a cool response from one of its biggest trading partners, Germany, where industries called for concrete actions
A
P
S
T

BioNTech gets US agency notice over default on COVID vaccine royalties

UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties Adds background in paragraphs 4-5 March 25 (Reuters) - BioNTech 22UAy.DE said on Monday the U.S. National Institutes of Health has sent a notice to the German company regarding default on the payment of royalties and other amounts related to its COVID-19 vaccine. BioNTech, which partnered with U.S.
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.